世界の伝染病治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Treatment for Communicable Diseases Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z5738 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、伝染病治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（HIV、インフルエンザ、結核、マラリア、肝炎、HPV）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・伝染病治療の市場動向 ・企業の競争状況、市場シェア ・伝染病治療の種類別市場規模（HIV、インフルエンザ、結核、マラリア、肝炎、HPV） ・伝染病治療の用途別市場規模（病院、診療所、その他） ・伝染病治療の北米市場規模2016-2027（アメリカ、カナダ） ・伝染病治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・伝染病治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・伝染病治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・伝染病治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Novartis、Gilead、GSK、Janssen Pharmaceutical、Roche、BioCryst Pharmaceuticals、Merck、Boehringer Ingelheim） ・結論

In this report, we study the drugs for Communicable Diseases. Communicable diseases are disorders caused by organisms — such as bacteria, viruses,fungi or parasites

Market Analysis and Insights: Global Treatment for Communicable Diseases Market
The global Treatment for Communicable Diseases market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Treatment for Communicable Diseases market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Treatment for Communicable Diseases market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Treatment for Communicable Diseases market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Treatment for Communicable Diseases market.

Global Treatment for Communicable Diseases Scope and Market Size
Treatment for Communicable Diseases market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Treatment for Communicable Diseases market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
HIV
Influenza
TB
Malaria
Hepatitis
HPV

Segment by Application
Hospital
Clinic
Other

By Region
North America
the United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Novartis
Gilead
GSK
Janssen Pharmaceutical
Roche
BioCryst Pharmaceuticals
Merck
Boehringer Ingelheim

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Treatment for Communicable Diseases Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 HIV
1.2.3 Influenza
1.2.4 TB
1.2.5 Malaria
1.2.6 Hepatitis
1.2.7 HPV
1.3 Market by Application
1.3.1 Global Treatment for Communicable Diseases Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Treatment for Communicable Diseases Market Perspective (2016-2027)
2.2 Treatment for Communicable Diseases Growth Trends by Regions
2.2.1 Treatment for Communicable Diseases Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Treatment for Communicable Diseases Historic Market Share by Regions (2016-2021)
2.2.3 Treatment for Communicable Diseases Forecasted Market Size by Regions (2022-2027)
2.3 Treatment for Communicable Diseases Industry Dynamic
2.3.1 Treatment for Communicable Diseases Market Trends
2.3.2 Treatment for Communicable Diseases Market Drivers
2.3.3 Treatment for Communicable Diseases Market Challenges
2.3.4 Treatment for Communicable Diseases Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Treatment for Communicable Diseases Players by Revenue
3.1.1 Global Top Treatment for Communicable Diseases Players by Revenue (2016-2021)
3.1.2 Global Treatment for Communicable Diseases Revenue Market Share by Players (2016-2021)
3.2 Global Treatment for Communicable Diseases Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Treatment for Communicable Diseases Revenue
3.4 Global Treatment for Communicable Diseases Market Concentration Ratio
3.4.1 Global Treatment for Communicable Diseases Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Treatment for Communicable Diseases Revenue in 2020
3.5 Treatment for Communicable Diseases Key Players Head office and Area Served
3.6 Key Players Treatment for Communicable Diseases Product Solution and Service
3.7 Date of Enter into Treatment for Communicable Diseases Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Treatment for Communicable Diseases Breakdown Data by Type
4.1 Global Treatment for Communicable Diseases Historic Market Size by Type (2016-2021)
4.2 Global Treatment for Communicable Diseases Forecasted Market Size by Type (2022-2027)

5 Treatment for Communicable Diseases Breakdown Data by Application
5.1 Global Treatment for Communicable Diseases Historic Market Size by Application (2016-2021)
5.2 Global Treatment for Communicable Diseases Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Treatment for Communicable Diseases Market Size (2016-2027)
6.2 North America Treatment for Communicable Diseases Market Size by Type
6.2.1 North America Treatment for Communicable Diseases Market Size by Type (2016-2021)
6.2.2 North America Treatment for Communicable Diseases Market Size by Type (2022-2027)
6.2.3 North America Treatment for Communicable Diseases Market Size by Type (2016-2027)
6.3 North America Treatment for Communicable Diseases Market Size by Application
6.3.1 North America Treatment for Communicable Diseases Market Size by Application (2016-2021)
6.3.2 North America Treatment for Communicable Diseases Market Size by Application (2022-2027)
6.3.3 North America Treatment for Communicable Diseases Market Size by Application (2016-2027)
6.4 North America Treatment for Communicable Diseases Market Size by Country
6.4.1 North America Treatment for Communicable Diseases Market Size by Country (2016-2021)
6.4.2 North America Treatment for Communicable Diseases Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Treatment for Communicable Diseases Market Size (2016-2027)
7.2 Europe Treatment for Communicable Diseases Market Size by Type
7.2.1 Europe Treatment for Communicable Diseases Market Size by Type (2016-2021)
7.2.2 Europe Treatment for Communicable Diseases Market Size by Type (2022-2027)
7.2.3 Europe Treatment for Communicable Diseases Market Size by Type (2016-2027)
7.3 Europe Treatment for Communicable Diseases Market Size by Application
7.3.1 Europe Treatment for Communicable Diseases Market Size by Application (2016-2021)
7.3.2 Europe Treatment for Communicable Diseases Market Size by Application (2022-2027)
7.3.3 Europe Treatment for Communicable Diseases Market Size by Application (2016-2027)
7.4 Europe Treatment for Communicable Diseases Market Size by Country
7.4.1 Europe Treatment for Communicable Diseases Market Size by Country (2016-2021)
7.4.2 Europe Treatment for Communicable Diseases Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Treatment for Communicable Diseases Market Size (2016-2027)
8.2 Asia-Pacific Treatment for Communicable Diseases Market Size by Type
8.2.1 Asia-Pacific Treatment for Communicable Diseases Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Treatment for Communicable Diseases Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Treatment for Communicable Diseases Market Size by Type (2016-2027)
8.3 Asia-Pacific Treatment for Communicable Diseases Market Size by Application
8.3.1 Asia-Pacific Treatment for Communicable Diseases Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Treatment for Communicable Diseases Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Treatment for Communicable Diseases Market Size by Application (2016-2027)
8.4 Asia-Pacific Treatment for Communicable Diseases Market Size by Region
8.4.1 Asia-Pacific Treatment for Communicable Diseases Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Treatment for Communicable Diseases Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Treatment for Communicable Diseases Market Size (2016-2027)
9.2 Latin America Treatment for Communicable Diseases Market Size by Type
9.2.1 Latin America Treatment for Communicable Diseases Market Size by Type (2016-2021)
9.2.2 Latin America Treatment for Communicable Diseases Market Size by Type (2022-2027)
9.2.3 Latin America Treatment for Communicable Diseases Market Size by Type (2016-2027)
9.3 Latin America Treatment for Communicable Diseases Market Size by Application
9.3.1 Latin America Treatment for Communicable Diseases Market Size by Application (2016-2021)
9.3.2 Latin America Treatment for Communicable Diseases Market Size by Application (2022-2027)
9.3.3 Latin America Treatment for Communicable Diseases Market Size by Application (2016-2027)
9.4 Latin America Treatment for Communicable Diseases Market Size by Country
9.4.1 Latin America Treatment for Communicable Diseases Market Size by Country (2016-2021)
9.4.2 Latin America Treatment for Communicable Diseases Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Treatment for Communicable Diseases Market Size (2016-2027)
10.2 Middle East & Africa Treatment for Communicable Diseases Market Size by Type
10.2.1 Middle East & Africa Treatment for Communicable Diseases Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Treatment for Communicable Diseases Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Treatment for Communicable Diseases Market Size by Type (2016-2027)
10.3 Middle East & Africa Treatment for Communicable Diseases Market Size by Application
10.3.1 Middle East & Africa Treatment for Communicable Diseases Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Treatment for Communicable Diseases Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Treatment for Communicable Diseases Market Size by Application (2016-2027)
10.4 Middle East & Africa Treatment for Communicable Diseases Market Size by Country
10.4.1 Middle East & Africa Treatment for Communicable Diseases Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Treatment for Communicable Diseases Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Treatment for Communicable Diseases Introduction
11.1.4 Novartis Revenue in Treatment for Communicable Diseases Business (2016-2021)
11.1.5 Novartis Recent Development
11.2 Gilead
11.2.1 Gilead Company Details
11.2.2 Gilead Business Overview
11.2.3 Gilead Treatment for Communicable Diseases Introduction
11.2.4 Gilead Revenue in Treatment for Communicable Diseases Business (2016-2021)
11.2.5 Gilead Recent Development
11.3 GSK
11.3.1 GSK Company Details
11.3.2 GSK Business Overview
11.3.3 GSK Treatment for Communicable Diseases Introduction
11.3.4 GSK Revenue in Treatment for Communicable Diseases Business (2016-2021)
11.3.5 GSK Recent Development
11.4 Janssen Pharmaceutical
11.4.1 Janssen Pharmaceutical Company Details
11.4.2 Janssen Pharmaceutical Business Overview
11.4.3 Janssen Pharmaceutical Treatment for Communicable Diseases Introduction
11.4.4 Janssen Pharmaceutical Revenue in Treatment for Communicable Diseases Business (2016-2021)
11.4.5 Janssen Pharmaceutical Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Treatment for Communicable Diseases Introduction
11.5.4 Roche Revenue in Treatment for Communicable Diseases Business (2016-2021)
11.5.5 Roche Recent Development
11.6 BioCryst Pharmaceuticals
11.6.1 BioCryst Pharmaceuticals Company Details
11.6.2 BioCryst Pharmaceuticals Business Overview
11.6.3 BioCryst Pharmaceuticals Treatment for Communicable Diseases Introduction
11.6.4 BioCryst Pharmaceuticals Revenue in Treatment for Communicable Diseases Business (2016-2021)
11.6.5 BioCryst Pharmaceuticals Recent Development
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Merck Business Overview
11.7.3 Merck Treatment for Communicable Diseases Introduction
11.7.4 Merck Revenue in Treatment for Communicable Diseases Business (2016-2021)
11.7.5 Merck Recent Development
11.8 Boehringer Ingelheim
11.8.1 Boehringer Ingelheim Company Details
11.8.2 Boehringer Ingelheim Business Overview
11.8.3 Boehringer Ingelheim Treatment for Communicable Diseases Introduction
11.8.4 Boehringer Ingelheim Revenue in Treatment for Communicable Diseases Business (2016-2021)
11.8.5 Boehringer Ingelheim Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Treatment for Communicable Diseases Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of HIV
Table 3. Key Players of Influenza
Table 4. Key Players of TB
Table 5. Key Players of Malaria
Table 6. Key Players of Hepatitis
Table 7. Key Players of HPV
Table 8. Global Treatment for Communicable Diseases Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Treatment for Communicable Diseases Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Treatment for Communicable Diseases Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Treatment for Communicable Diseases Market Share by Regions (2016-2021)
Table 12. Global Treatment for Communicable Diseases Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Treatment for Communicable Diseases Market Share by Regions (2022-2027)
Table 14. Treatment for Communicable Diseases Market Trends
Table 15. Treatment for Communicable Diseases Market Drivers
Table 16. Treatment for Communicable Diseases Market Challenges
Table 17. Treatment for Communicable Diseases Market Restraints
Table 18. Global Treatment for Communicable Diseases Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Treatment for Communicable Diseases Market Share by Players (2016-2021)
Table 20. Global Top Treatment for Communicable Diseases Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Treatment for Communicable Diseases as of 2020)
Table 21. Ranking of Global Top Treatment for Communicable Diseases Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Treatment for Communicable Diseases Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Treatment for Communicable Diseases Product Solution and Service
Table 25. Date of Enter into Treatment for Communicable Diseases Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Treatment for Communicable Diseases Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Treatment for Communicable Diseases Revenue Market Share by Type (2016-2021)
Table 29. Global Treatment for Communicable Diseases Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Treatment for Communicable Diseases Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Treatment for Communicable Diseases Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Treatment for Communicable Diseases Revenue Market Share by Application (2016-2021)
Table 33. Global Treatment for Communicable Diseases Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Treatment for Communicable Diseases Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Treatment for Communicable Diseases Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Treatment for Communicable Diseases Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Treatment for Communicable Diseases Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Treatment for Communicable Diseases Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Treatment for Communicable Diseases Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Treatment for Communicable Diseases Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Treatment for Communicable Diseases Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Treatment for Communicable Diseases Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Treatment for Communicable Diseases Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Treatment for Communicable Diseases Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Treatment for Communicable Diseases Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Treatment for Communicable Diseases Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Treatment for Communicable Diseases Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Treatment for Communicable Diseases Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Treatment for Communicable Diseases Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Treatment for Communicable Diseases Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Treatment for Communicable Diseases Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Treatment for Communicable Diseases Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Treatment for Communicable Diseases Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Treatment for Communicable Diseases Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Treatment for Communicable Diseases Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Treatment for Communicable Diseases Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Treatment for Communicable Diseases Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Treatment for Communicable Diseases Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Treatment for Communicable Diseases Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Treatment for Communicable Diseases Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Treatment for Communicable Diseases Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Treatment for Communicable Diseases Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Treatment for Communicable Diseases Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Treatment for Communicable Diseases Market Size by Country (2022-2027) & (US$ Million)
Table 65. Novartis Company Details
Table 66. Novartis Business Overview
Table 67. Novartis Treatment for Communicable Diseases Product
Table 68. Novartis Revenue in Treatment for Communicable Diseases Business (2016-2021) & (US$ Million)
Table 69. Novartis Recent Development
Table 70. Gilead Company Details
Table 71. Gilead Business Overview
Table 72. Gilead Treatment for Communicable Diseases Product
Table 73. Gilead Revenue in Treatment for Communicable Diseases Business (2016-2021) & (US$ Million)
Table 74. Gilead Recent Development
Table 75. GSK Company Details
Table 76. GSK Business Overview
Table 77. GSK Treatment for Communicable Diseases Product
Table 78. GSK Revenue in Treatment for Communicable Diseases Business (2016-2021) & (US$ Million)
Table 79. GSK Recent Development
Table 80. Janssen Pharmaceutical Company Details
Table 81. Janssen Pharmaceutical Business Overview
Table 82. Janssen Pharmaceutical Treatment for Communicable Diseases Product
Table 83. Janssen Pharmaceutical Revenue in Treatment for Communicable Diseases Business (2016-2021) & (US$ Million)
Table 84. Janssen Pharmaceutical Recent Development
Table 85. Roche Company Details
Table 86. Roche Business Overview
Table 87. Roche Treatment for Communicable Diseases Product
Table 88. Roche Revenue in Treatment for Communicable Diseases Business (2016-2021) & (US$ Million)
Table 89. Roche Recent Development
Table 90. BioCryst Pharmaceuticals Company Details
Table 91. BioCryst Pharmaceuticals Business Overview
Table 92. BioCryst Pharmaceuticals Treatment for Communicable Diseases Product
Table 93. BioCryst Pharmaceuticals Revenue in Treatment for Communicable Diseases Business (2016-2021) & (US$ Million)
Table 94. BioCryst Pharmaceuticals Recent Development
Table 95. Merck Company Details
Table 96. Merck Business Overview
Table 97. Merck Treatment for Communicable Diseases Product
Table 98. Merck Revenue in Treatment for Communicable Diseases Business (2016-2021) & (US$ Million)
Table 99. Merck Recent Development
Table 100. Boehringer Ingelheim Company Details
Table 101. Boehringer Ingelheim Business Overview
Table 102. Boehringer Ingelheim Revenue in Treatment for Communicable Diseases Business (2016-2021) & (US$ Million)
Table 103. Boehringer Ingelheim Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Treatment for Communicable Diseases Market Share by Type: 2020 VS 2027
Figure 2. HIV Features
Figure 3. Influenza Features
Figure 4. TB Features
Figure 5. Malaria Features
Figure 6. Hepatitis Features
Figure 7. HPV Features
Figure 8. Global Treatment for Communicable Diseases Market Share by Application: 2020 VS 2027
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Other Case Studies
Figure 12. Treatment for Communicable Diseases Report Years Considered
Figure 13. Global Treatment for Communicable Diseases Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Treatment for Communicable Diseases Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Treatment for Communicable Diseases Market Share by Regions: 2020 VS 2027
Figure 16. Global Treatment for Communicable Diseases Market Share by Regions (2022-2027)
Figure 17. Global Treatment for Communicable Diseases Market Share by Players in 2020
Figure 18. Global Top Treatment for Communicable Diseases Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Treatment for Communicable Diseases as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Treatment for Communicable Diseases Revenue in 2020
Figure 20. Global Treatment for Communicable Diseases Revenue Market Share by Type (2016-2021)
Figure 21. Global Treatment for Communicable Diseases Revenue Market Share by Type (2022-2027)
Figure 22. North America Treatment for Communicable Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Treatment for Communicable Diseases Market Share by Type (2016-2027)
Figure 24. North America Treatment for Communicable Diseases Market Share by Application (2016-2027)
Figure 25. North America Treatment for Communicable Diseases Market Share by Country (2016-2027)
Figure 26. United States Treatment for Communicable Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Treatment for Communicable Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Treatment for Communicable Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Treatment for Communicable Diseases Market Share by Type (2016-2027)
Figure 30. Europe Treatment for Communicable Diseases Market Share by Application (2016-2027)
Figure 31. Europe Treatment for Communicable Diseases Market Share by Country (2016-2027)
Figure 32. Germany Treatment for Communicable Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Treatment for Communicable Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Treatment for Communicable Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Treatment for Communicable Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Treatment for Communicable Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Treatment for Communicable Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Treatment for Communicable Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Treatment for Communicable Diseases Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Treatment for Communicable Diseases Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Treatment for Communicable Diseases Market Share by Region (2016-2027)
Figure 42. China Treatment for Communicable Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Treatment for Communicable Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Treatment for Communicable Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Treatment for Communicable Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Treatment for Communicable Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Treatment for Communicable Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Treatment for Communicable Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Treatment for Communicable Diseases Market Share by Type (2016-2027)
Figure 50. Latin America Treatment for Communicable Diseases Market Share by Application (2016-2027)
Figure 51. Latin America Treatment for Communicable Diseases Market Share by Country (2016-2027)
Figure 52. Mexico Treatment for Communicable Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Treatment for Communicable Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Treatment for Communicable Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Treatment for Communicable Diseases Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Treatment for Communicable Diseases Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Treatment for Communicable Diseases Market Share by Country (2016-2027)
Figure 58. Turkey Treatment for Communicable Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Treatment for Communicable Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Treatment for Communicable Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Novartis Revenue Growth Rate in Treatment for Communicable Diseases Business (2016-2021)
Figure 62. Gilead Revenue Growth Rate in Treatment for Communicable Diseases Business (2016-2021)
Figure 63. GSK Revenue Growth Rate in Treatment for Communicable Diseases Business (2016-2021)
Figure 64. Janssen Pharmaceutical Revenue Growth Rate in Treatment for Communicable Diseases Business (2016-2021)
Figure 65. Roche Revenue Growth Rate in Treatment for Communicable Diseases Business (2016-2021)
Figure 66. BioCryst Pharmaceuticals Revenue Growth Rate in Treatment for Communicable Diseases Business (2016-2021)
Figure 67. Merck Revenue Growth Rate in Treatment for Communicable Diseases Business (2016-2021)
Figure 68. Boehringer Ingelheim Revenue Growth Rate in Treatment for Communicable Diseases Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

---